Infinity Pharmaceuticals, Inc. (INFI)

1 member of Congress has disclosed 3 trades in Infinity Pharmaceuticals, Inc. (INFI) via STOCK Act filings. The most recent disclosure was a purchase by Roger Marshall on 12 October 2017. Aggregate disclosed activity totals roughly $24K in purchases (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for INFI
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for INFI

3 transactions
Compliance: 0%
Roger Marshall12 Oct 201713 Aug 2020PurchaseStock$1,001 - $15,000N/A
Roger Marshall12 Oct 20176 Aug 2018PurchaseStock$1,001 - $15,000N/A
Roger Marshall12 Oct 201710 Aug 2018PurchaseStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$726.09K

Volume

2.48M

Beta

1.38

P/E Ratio

-0.02

Fundamentals

EPS

$-0.44

Div. Yield

-

Open

$0.02

Day Range

$0.01 – $0.01

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Seth A. Tasker
IPO Date
2000-07-28
Website
www.infi.com

Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge, Massachusetts, operates as a biopharmaceutical firm dedicated to creating innovative therapies for individuals battling cancer. A central component of its pipeline is IPI-549...

Earnings

Recent Quarters

Q2 20248 Aug
EPS-
Q1 20247 May
EPS-
Q4 202326 Mar
EPS-
Q3 202313 Nov
EPS-
Q2 20238 Aug
EPS$-0.11
Beat 8.3%
Q1 20239 May
EPS$-0.12
Miss 9.1%
Q3 202231 Dec
EPS$-0.10
Q3 202214 Nov
EPS$-0.12
Miss 140.0%
Q2 20229 Aug
EPS$-0.13
Beat 7.1%
Q1 20223 May
EPS$-0.14
Beat 0.0%
Q3 202131 Dec
EPS$-0.13
Q3 20212 Nov
EPS$-0.12
Beat 14.3%
Q2 202127 Jul
EPS$-0.13
Beat 0.0%
Q1 202113 May
EPS$-0.15
Miss 7.1%
Q4 202016 Mar
EPS$-0.17
Miss 6.3%
Q3 20209 Nov
EPS$-0.16
Miss 6.7%
Q2 202030 Jul
EPS$-0.16
Beat 20.0%
Q1 202011 May
EPS$-0.19
Miss 111.1%
Q4 20193 Mar
EPS$-0.20
Miss 5.3%
Q3 201930 Oct
EPS$-0.20
Miss 11.1%
Q2 201930 Jul
EPS$-0.18
Miss 20.0%
Q1 20197 May
EPS$-0.24
Miss 380.0%
Q4 201814 Mar
EPS$-0.14
Beat 17.6%
Q3 20185 Nov
EPS$0.23
Beat 253.3%
Q2 20187 Aug
EPS$-0.12
Beat 40.0%
Q1 20188 May
EPS$-0.18
Beat 0.0%
Q4 201715 Mar
EPS$-0.14
Beat 48.1%
Q3 20177 Nov
EPS$-0.14
Beat 33.3%
Q2 20173 Aug
EPS$-0.34
Miss 54.5%
Q1 20179 May
EPS$-0.21
Beat 4.5%
Q4 201614 Mar
EPS$-0.46
Beat 19.3%
Q3 20169 Nov
EPS$-0.39
Beat 53.6%
Q2 20169 Aug
EPS$-0.43
Beat 51.7%
Q1 20164 May
EPS$-0.82
Beat 4.7%
Q4 201523 Feb
EPS$-0.80
Beat 3.6%
Q3 20155 Nov
EPS$0.84
Beat 252.7%
Q2 20156 Aug
EPS$-0.78
Beat 20.4%
Q1 20156 May
EPS$-1.91
Miss 24.0%
Q4 201424 Feb
EPS$-0.83
Beat 16.2%
Q3 20146 Nov
EPS$2.03
Beat 336.1%
Q2 20145 Aug
EPS$-0.78
Beat 4.9%
Q1 20146 May
EPS$-0.87
Miss 8.8%
Q4 201325 Feb
EPS$-0.68
Beat 18.1%
Q3 20137 Nov
EPS$-0.71
Beat 4.0%
Q2 20138 Aug
EPS$-0.68
Miss 9.7%
Q1 20137 May
EPS$-0.57
Beat 14.9%
Q4 20125 Mar
EPS$-1.15
Miss 29.2%
Q3 20126 Nov
EPS$-0.80
Miss 19.4%
Q2 20127 Aug
EPS$-0.54
Miss 42.1%
Q1 20128 May
EPS$-0.40
Miss 8.1%
Q4 201113 Mar
EPS$-0.53
Miss 26.2%
Q3 20118 Nov
EPS$-0.45
Miss 7.1%
Q2 20119 Aug
EPS$-0.44
Miss 22.2%
Q1 201110 May
EPS$-0.09
Beat 75.0%
Q4 201015 Mar
EPS$-0.53
Miss 35.9%
Q3 20109 Nov
EPS$-0.81
Miss 6.6%
Q2 20104 Aug
EPS$-0.24
Beat 25.0%
Q1 20106 May
EPS$-0.32
Beat 5.9%
Q4 200910 Feb
EPS$-0.30
Beat 28.6%
Q3 20099 Nov
EPS$-0.36
Beat 18.2%
Q2 20095 Aug
EPS$-0.43
Beat 12.2%
Q1 20094 May
EPS$-0.15
Miss 114.3%
Q4 20089 Feb
EPS$2.11
Beat 108.9%
Q3 200829 Oct
EPS$-0.63
Miss 16.7%
Q2 20084 Aug
EPS$-0.57
Miss 26.7%
Q1 20085 May
EPS$0.02
Beat 105.6%
Q4 200713 Feb
EPS$-0.40
Miss 66.7%
Q3 200729 Oct
EPS$-0.10
Beat 69.7%
Q2 20071 Aug
EPS$-0.21
Beat 27.6%
Q1 200730 Apr
EPS$-0.15
Beat 44.4%
Q4 20067 Feb
EPS$-0.27
Beat 50.0%
Q2 200630 Sept
EPS$-0.83
Q1 200630 Jun
EPS$-1.81
Q1 20064 May
EPS$-1.40
Miss 150.0%
Q3 200531 Dec
EPS$-1.20
Q3 20051 Nov
EPS$-0.16
Beat 60.0%
Q2 20052 Aug
EPS$-0.20
Miss 25.0%
Q1 20053 May
EPS$-0.72
Miss 260.0%
Q4 20041 Mar
EPS$0.20
Beat 11.1%
Q3 20042 Nov
EPS$0.12
Beat 0.0%
Q2 200420 Jul
EPS$0.12
Beat 0.0%
Q1 200420 Apr
EPS$0.16
Beat 33.3%
Q4 200310 Feb
EPS$0.24
Beat 100.0%
Q3 200321 Oct
EPS$0.12
Beat 200.0%
Q2 200322 Jul
EPS$0.04
Beat 100.0%
Q1 200322 Apr
EPS$0.04
Beat 200.1%
Q4 200211 Feb
EPS$0.04
Beat 200.1%
Q3 200222 Oct
EPS$-0.12
Beat 25.0%
Q2 200223 Jul
EPS$-1.60
Miss 1900.0%
Q1 200223 Apr
EPS$-0.12
Beat 0.0%
Q4 200112 Feb
EPS$-0.28
Miss 12.0%
Q3 200130 Oct
EPS$-1.08
Beat 0.0%
Q2 200131 Jul
EPS$-0.16
Miss 33.3%
Q1 20011 May
EPS$-0.36
Q4 200015 Feb
EPS$-0.04
Beat 55.6%
Q3 200031 Oct
EPS$-0.12
Beat 40.0%
Q1 200030 Jun
EPS$-4.13
Q4 199931 Mar
EPS$-4.93
Q3 199931 Dec
EPS$-3.50
Q2 199930 Sept
EPS$-1.67
Q1 199930 Jun
EPS$-2.00
Q4 199831 Mar
EPS$-3.33

3 politicians traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

13 Sept 2006Reverse Split
Ratio1:4

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about INFI

Which members of Congress have traded INFI?
1 member of Congress has disclosed 3 trade in Infinity Pharmaceuticals, Inc. (INFI) under the STOCK Act: Roger Marshall.
When was INFI most recently disclosed by Congress?
The most recent INFI disclosure was a purchase by Roger Marshall on 12 October 2017.
What is the total disclosed congressional trading volume for INFI?
Members of Congress have disclosed approximately $24K in INFI purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in INFI?
This INFI page updates as soon as new STOCK Act disclosures are filed for Infinity Pharmaceuticals, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.